hepatitis-c

Documents about hepatitis-c

• Community Access, Retention in Care, and Engagement for Hepatitis C Treatment#875151ClinicalTrials.gov
• The epidemiology of the viral hepatitis in Brazil: A scoping review#379064PLOS
• An Observational Study of Hepatitis C Virus in Pregnancy#127780ClinicalTrials.gov
• Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C#863398ClinicalTrials.gov
• Transplanting Hepatitis C Positive Organs#912406ClinicalTrials.gov
• Immune Response to Hepatitis C Virus#914292ClinicalTrials.gov
• A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients#969927ClinicalTrials.gov
• Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C#813845ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis#830512ClinicalTrials.gov
• Assessing the hepatitis C virus birth-cohort screening practices and cascade of care in an urban community hospital#462375RUcore, Rutgers University Community Repository
• SH229 Tablets Combined With Daclatasvir Dihydrochloride Tablets in Treatment Adult Patients With Chronic Hepatitis C#856397ClinicalTrials.gov
• Surveillance and Treatment of Prisoners With Hepatitis C#862773ClinicalTrials.gov
• A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C#826562ClinicalTrials.gov
• Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases#445037Dipòsit Digital de la Universitat de Barcelona
• Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Administrative Detention Center#905880ClinicalTrials.gov
• Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection#852053ClinicalTrials.gov
• The Effect of Adding Metformin to the Treatment of Hepatitis C#405121ClinicalTrials.gov
• Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C#845026ClinicalTrials.gov
• Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel#858781ClinicalTrials.gov
• Transmission of Chronic Hepatitis C in Pregnancy#875673ClinicalTrials.gov
• Identifying the Gaps in the Diagnosis and Management of Hepatitis C#981797ClinicalTrials.gov
• Low-Barrier Fibrosis Screening in Hepatitis C Treatment: The Decompensated Cirrhosis in Hepatitis C Evaluation Questionnaire#205457Europe PMC
• A novel dimerization site in non-structural protein 5A of hepatitis C virus regulates viral replication fitness#431417PLOS
• Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection#829671ClinicalTrials.gov
• Effectiveness and Safety of Direct-Acting Antiviral Agents for the Treatment of Chronic Hepatitis C#849120ClinicalTrials.gov
• Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy#862792ClinicalTrials.gov
• Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection#891564ClinicalTrials.gov
• Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)#979370ClinicalTrials.gov
• Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis#982052ClinicalTrials.gov
• Phase I-II Vaccination of Autologous Dendritic Cells Transduced With Adenoviral Vector Encoding NS3 in Hepatitis C Encoding NS3 in Hepatitis C#245578ClinicalTrials.gov
• Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C#834540ClinicalTrials.gov
• Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients#913343ClinicalTrials.gov
• Screening, Treatment, and Eradication of Hep C#852810ClinicalTrials.gov
• Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy#843719ClinicalTrials.gov
• Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients#858452ClinicalTrials.gov
• Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs#865429ClinicalTrials.gov
• Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C#1007872ClinicalTrials.gov
• Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta-analysis.#281630Repisalud
• Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C#856297ClinicalTrials.gov
• A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C#991845ClinicalTrials.gov
• Recommendations and guidance on hepatitis C virus self-testing: web annex F: cost-effectiveness of hepatitis C virus self-testing#404861WHO IRIS
• Australian Hepatitis and Risk Survey in Prisons#810143ClinicalTrials.gov
• Recently acquired hepatitis C: Epidemiological characteristics and treatment response in a large cohort of MSM living with HIV in Madrid.#276168Repisalud
• Genetics of Hepatitis C Virus Infection#28537ClinicalTrials.gov
• Gamma Interferon Therapy for Chronic Hepatitis C#373721ClinicalTrials.gov
• Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C#471519ClinicalTrials.gov
• Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus#840518ClinicalTrials.gov
• Hepatitis C Pharmacy-based Strategy for Injectors#863954ClinicalTrials.gov
• Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC)#883968ClinicalTrials.gov
• Study to Describe the Actual Situation of Hepatitis C Treatment in Brazil#886728ClinicalTrials.gov